September 3, 2025 - 18:57

In a significant move for the decentralized finance (DeFi) sector, Ondo Finance has launched a new initiative that introduces 100 tokenized stocks on the Ethereum blockchain. This development aims to provide users with greater access to traditional equity markets through the innovative use of blockchain technology. By tokenizing these stocks, Ondo Finance enables seamless trading and ownership transfer, making it easier for investors to diversify their portfolios.
The company has expressed ambitions to expand its offerings beyond Ethereum, with plans to bring these tokenized stocks to the Solana blockchain in the near future. This expansion could enhance accessibility and liquidity for investors, tapping into Solana's growing ecosystem. The integration of tokenized stocks into the DeFi space represents a pivotal step in bridging traditional finance and digital assets, promising to reshape how investors engage with the stock market. As the DeFi landscape continues to evolve, Ondo Finance is positioning itself at the forefront of this transformation.
June 3, 2026 - 07:37
Japan finance minister says ready to respond appropriately on forexTOKYO, June 3 - Japanese Finance Minister Satsuki Katayama stated on Wednesday that the government is prepared to take appropriate measures in the foreign exchange market, issuing a fresh warning...
June 2, 2026 - 17:28
Thrifts & Mortgage Finance Stocks Q1 Results: Benchmarking Franklin BSP Realty Trust (NYSE:FBRT)The close of earnings season offers a useful moment to check in on how different sectors are navigating the current economic climate. For investors keeping an eye on thrifts and mortgage finance...
June 2, 2026 - 05:00
HPE expects to achieve 2028 financial targets this year after record quarter on AI boomHewlett Packard Enterprise reported record revenue for its second fiscal quarter on Monday, driven by surging demand for AI data center infrastructure. The strong performance has led the company to...
June 1, 2026 - 02:50
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First QuarterA recent $5.5 million executive departure at Wave Life Sciences has drawn scrutiny following the company`s disappointing first-quarter performance. The clinical-stage biotech, which develops...